Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 April, 2018 08:23 IST
Alembic Pharma gets USFDA's tentative nod for Vilazodone HCl tablets
Source: IRIS | 19 Apr, 2017, 11.14AM
Comments  |  Post Comment

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vilazodone Hydrochloride Tablets, 10mg, 20mg and 40mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Viibryd Tablets, 10 mg, 20mg and 40mg, of Forest Labs LLC. Vilazodone Hydrochloride Tablets are indicated for the treatment of Major Depressive Disorder (MDD). Alembic is currently in litigation with Forest Labs LLC in District Court of Delaware and has stipulated to stay the case in view of the ongoing settlement discussions.

Vilazodone Hydrochloride Tablets have an estimated market size of USD 340 million for twelve months ending December 2016 according to IMS.

Alembic now has a total of 54 ANDA approvals (47 final approvals and 7 tentative approvals) from the USFDA.

Shares of the company gained Rs 12, or 1.97%, to trade at Rs 621.95. The total volume of shares traded was 7,783 at the BSE (11.05 a.m., Wednesday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Thomas Cook signs an MoU with Tourism NZ and Immigration NZ - 24-Apr-2018 16:08
Network18 Media & Investments loss widens in Jan-Mar quarter - 24-Apr-2018 15:06
Coromandel International quarterly profit plunges 49% - 24-Apr-2018 14:55
GATI surges over 17%; to explore inducting a strategic partner - 24-Apr-2018 12:47
TCS signs ICT infrastructure contract with Bonnier AB - 24-Apr-2018 12:37
KP Energy to develop 300 MW wind power project in Gujarat - 24-Apr-2018 11:36
Biocon gains 3% as Pfizer's Herceptin biosimilar delayed further - 24-Apr-2018 10:33
Jet Airways signs codeshare pact with Aeromexico - 24-Apr-2018 10:24
Bharti Airtel announces plans for massive network expansion in Gujarat - 24-Apr-2018 10:16
Astron Paper enters into MoU with promoters of Balaram Papers - 24-Apr-2018 10:10
Hindustan Copper signs MoU with MOIL - 24-Apr-2018 10:01
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer